Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients
about
New developments in the treatment of gram-negative bacteremia.Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.Controversies in the management of febrile neutropenic cancer patients.Microbiology, pharmacology, and clinical use of mezlocillin sodium.Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.Imipenem/cilastatin therapy of infections in cancer patients.
P2860
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients
description
1980 nî lūn-bûn
@nan
1980 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@ast
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@en
type
label
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@ast
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@en
prefLabel
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@ast
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@en
P2093
P2860
P356
P1476
Potential of mezlocillin as em ...... anulocytopenic cancer patients
@en
P2093
Fortner CL
Schimpff SC
Wiernik PH
P2860
P304
P356
10.1128/AAC.18.2.299
P407
P577
1980-08-01T00:00:00Z